| Radiofrequency Non-ablation in the Treatment of Women With Urinary Stress Incontinence: Study Pilot (NCT02623842) | Centro de Atenção ao Assoalho Pélvico | 2013-07-01 |
| Assessment of the Single Dose Pharmacokinetics and Tolerability of Sativex in Patients With Impaired Hepatic Function and Healthy Patients (NCT01887301) | Jazz Pharmaceuticals | 2013-07-01 |
| Peripheral Stimulation Device to Improve Coronary Flow Reserve in Coronary Artery Disease (NCT01853410) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-07-01 |
| Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects (NCT01934166) | H. Lundbeck A/S | 2013-07-01 |
| A Study of BI 853520 in Japanese and Taiwanese Patients With Various Types of Advanced or Metastatic Cancer (NCT01905111) | Boehringer Ingelheim | 2013-07-01 |
| To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors (NCT01922752) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-07-01 |
| Study to Investigate the Safety Profile of AZD4721 After Single Doses at Different Dose Levels (NCT01889160) | AstraZeneca | 2013-07-01 |
| Effects of Octanoic Acid for Treatment of Essential Voice Tremor (NCT01864525) | Syracuse University | 2013-07-01 |
| A Clinical Trial to Investigate the Influence of CES1 Polymorphism on Oseltamivir (NCT01902342) | Seoul National University Hospital | 2013-07-01 |
| Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults (NCT01967264) | Takeda | 2013-07-01 |
| Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-427 When Given to Patients With Advanced and Refractory Solid Tumors or Lymphoma (NCT01908413) | Curis, Inc. | 2013-07-01 |
| Chemoimmunotherapy and Radiation in Pancreatic Cancer (NCT01903083) | Providence Health & Services | 2013-07-01 |
| A Study of Evacetrapib (LY2484595) in Healthy Participants (NCT01903434) | Eli Lilly and Company | 2013-07-01 |
| Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury (NCT01484184) | Nordic Life Science Pipeline Inc. | 2013-07-01 |
| An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate (NCT01844869) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-07-01 |
| Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors (NCT01908010) | AbbVie | 2013-07-01 |
| A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions (NCT01879683) | Allergan | 2013-07-01 |
| Safety and Tolerability Study of ARC-520 in Healthy Volunteers (NCT01872065) | Arrowhead Pharmaceuticals | 2013-07-01 |
| A Study to Compare the Pharmacodynamics of Canagliflozin and Dapagliflozin in Healthy Volunteers (NCT01877889) | Janssen-Cilag International NV | 2013-07-01 |
| Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents (NCT01919554) | Stallergenes Greer | 2013-07-01 |
| Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A) (NCT02057887) | Hanmi Pharmaceutical Company Limited | 2013-07-01 |
| Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus (NCT01460888) | The Christie NHS Foundation Trust | 2013-07-01 |
| Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. (NCT01838694) | Invion, Inc. | 2013-07-01 |
| Protein Ingestion and Muscle Carnitine Uptake (NCT02535897) | University of Nottingham | 2013-07-01 |
| Human Mesenchymal Stem Cells For Acute Respiratory Distress Syndrome (NCT01775774) | Michael A. Matthay | 2013-07-01 |
| An Open Label Study to Describe the Pharmacokinetics of Cefazolin in Preterm Neonates (NCT00850122) | Phillip Brian Smith | 2013-07-01 |
| A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384 (NCT02963077) | Albireo | 2013-07-01 |
| The Drug-drug Interaction of SP2086 and Simvastatin (NCT02815722) | Jiangsu HengRui Medicine Co., Ltd. | 2013-07-01 |
| Complementary and Alternative Medicine Sauna Detoxification Study: Phase I (NCT01905098) | Bastyr University | 2013-07-01 |
| A Phase 1 Study to Investigate the Food Effect of Lumacaftor in Combination With Ivacaftor (NCT01899105) | Vertex Pharmaceuticals Incorporated | 2013-07-01 |
| Trial to Study the Safety of Intravenous MNK-010 in Advanced Solid Tumors (NCT02040558) | Mallinckrodt | 2013-07-01 |
| Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AE58054 in Healthy Japanese and Caucasian Subjects (NCT01975779) | H. Lundbeck A/S | 2013-07-01 |
| ALX-0171 Safety Study in Adults With Hyperresponsive Airways (NCT01909843) | Ablynx, a Sanofi company | 2013-07-01 |
| Phase I Study to Investigate Safety, Tolerability, and Pharmacokinetics of VVZ-149 Injection (NCT01905410) | Vivozon, Inc. | 2013-07-01 |
| Phase I Study of WX-037 Alone and in Combination With WX-554 in Solid Tumours (NCT01859351) | Heidelberg Pharma AG | 2013-07-01 |
| Study Comparing the Bioavailability of TAS-102 Tablets to an Oral Solution Containing Equivalent Amounts of FTD and TPI (NCT01874522) | Taiho Oncology, Inc. | 2013-07-01 |
| DC Vaccine Combined With CIK Cells in Patients With Renal Cell Carcinoma (NCT01924156) | Affiliated Hospital to Academy of Military Medical Sciences | 2013-07-01 |
| A Study of MHAA4549A to Assess Safety And Pharmacokinetics in Healthy Volunteers (NCT01877785) | Genentech, Inc. | 2013-07-01 |
| Safety and Tolerability Study of ZEP-3 Cream (0.1% and 1.0%), Administered Topically In Healthy Volunteers (NCT01863160) | Shulov Innovate for Science Ltd. 2012 | 2013-07-01 |
| A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf) (NCT01765543) | Hoffmann-La Roche | 2013-07-01 |
| A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm (NCT01905228) | Incuron | 2013-07-01 |
| Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood (NCT01899846) | Lumara Health, Inc. | 2013-07-01 |
| Pharmacokinetic Interactions of Bisoprolol and Rosuvastatin (NCT01925300) | HK inno.N Corporation | 2013-07-01 |
| Effects of Viscous Fibre Containing Foods on Satiety (Gel Form) (NCT02134938) | Unity Health Toronto | 2013-07-01 |
| Oral Bioavailability of Two Solid Formulations of GLPG0634 (NCT01915667) | Lakefront Biotherapeutics NV | 2013-07-01 |
| Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation (NCT01610999) | Tufts Medical Center | 2013-07-01 |
| Phase I Study of Olaparib and Temozolomide for Ewings Sarcoma or Rhabdoomyosarcoma (NCT01858168) | Massachusetts General Hospital | 2013-07-01 |
| Consumption of Milk Drink and Constipation (NCT02091115) | Centro Universitário Univates | 2013-07-01 |
| PI3K Inhibitor BKM120, Carboplatin, and Pemetrexed Disodium in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT01723800) | City of Hope Medical Center | 2013-07-01 |
| Clinical Drug Trial in Healthy Male Subjects to Determine and Compare the Blood Concentrations of BI 144807 Following Administration as Oral Solution and Tablet Under Fasted and Fed Conditions (NCT01897597) | Boehringer Ingelheim | 2013-07-01 |
| A First-in-Human Safety and Dose-Finding Study of New Type-16 Human Rhinovirus (RG-HRV16) Inoculum in Healthy Volunteers (NCT01769573) | University of Wisconsin, Madison | 2013-07-01 |
| Gene Therapy for X-CGD (NCT01906541) | Hubert Serve, Prof., MD | 2013-07-01 |
| (-)-Epicatechin and Pulmonary Arterial Hypertension (NCT01880866) | University of California, San Francisco | 2013-07-01 |
| A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men (NCT02138799) | Astellas Pharma Europe B.V. | 2013-07-01 |
| A Study of RO6799477 in Healthy Volunteers (NCT01893437) | Hoffmann-La Roche | 2013-07-01 |
| A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma (NCT01697514) | Eli Lilly and Company | 2013-07-01 |
| A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients (NCT01921712) | Pulmatrix Inc. | 2013-07-01 |
| Study to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration. (NCT01887626) | AstraZeneca | 2013-07-01 |
| Determining the Effect of Actimmune (Interferon Gamma 1b)Dose Titration on Flu-Like Symptoms in Healthy Volunteers (NCT01929382) | Vidara Therapeutics Research Ltd | 2013-07-01 |
| Effect of LIK066 on Glucose Absorption in Patients With Type 2 Diabetes Mellitus (NCT01915849) | Novartis Pharmaceuticals | 2013-07-01 |
| Cranial Reconstruction Using Mesenchymal Stromal Cells and Resorbable Biomaterials (NCT01742260) | R.P.Herrmann | 2013-07-01 |
| Phase 1 Study to Evaluate Safety of GR-MD-02 in Subjects With Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis (NCT01899859) | Galectin Therapeutics Inc. | 2013-07-01 |
| In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma (NCT02759536) | The Third Xiangya Hospital of Central South University | 2013-07-01 |
| Tissue Procurement Substudy for Participants in Study CP-MGA271-01 (NCT01918930) | MacroGenics | 2013-07-01 |
| Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B Vaccine (NCT01951677) | Vaxine Pty Ltd | 2013-07-01 |
| Safety Study of VBY-036 in Healthy Volunteers After 7 Days of Oral Dosing (NCT01892891) | Virobay Inc. | 2013-07-01 |
| Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone (NCT02777268) | Neurocrine UK Limited | 2013-07-01 |
| Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure (NCT01844063) | Third Affiliated Hospital, Sun Yat-Sen University | 2013-07-01 |
| A Study of rSIFN-co in Subjects With Advanced Solid Tumors (NCT02387307) | Sichuan Huiyang Life Science and Technology Corporation | 2013-07-01 |
| Efficacy of Latanoprostene Bunod in Lowering Intraocular Pressure in Japanese Healthy Male Volunteers (NCT01895985) | Bausch & Lomb Incorporated | 2013-07-01 |
| Safety and Pharmacokinetic Characteristics of HD203 Liquid in Healthy Male Volunteers (NCT01894412) | Hanwha Chemical | 2013-07-01 |
| Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male Subjects (NCT01941199) | Dong-A Pharmaceutical Co., Ltd. | 2013-07-01 |
| Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD) (NCT02253745) | Vernalis (R&D) Ltd | 2013-07-01 |
| A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA) (NCT01904279) | Hoffmann-La Roche | 2013-07-01 |
| Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy -- Use in Acute Cholecystitis Sub-Study (NCT02070627) | Ohio State University | 2013-07-01 |
| Compare Safety and Pharmacokinetic Properties of Surfolase Capsule(Acebrophylline 100mg) and Surfolase CR(200mg) (NCT02395913) | Hyundai Pharmaceutical Co., LTD. | 2013-07-01 |
| Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer (NCT01913015) | OHSU Knight Cancer Institute | 2013-07-01 |
| Safety, Tolerability, Immunogenicity and Efficacy of NDV-3A Vaccine in Preventing Recurrent Vulvovaginal Candidiasis (NCT01926028) | NovaDigm Therapeutics, Inc. | 2013-07-01 |
| PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative (NCT01916135) | Memorial Sloan Kettering Cancer Center | 2013-07-01 |
| A Pharmacokinetics Study to Investigate the Effect of Vemurafenib on Digoxin in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma (NCT01765569) | Hoffmann-La Roche | 2013-07-01 |
| Pharmacokinetic and in Vitro Transmission Blocking Activities Study of Primaquine Compare to Methylene Blue in Healthy Volunteer Both G6PD Normal and G6PD Deficiency (NCT01668433) | University of Oxford | 2013-07-01 |
| Efficacy Study of Trichuris Suis Ova to Treat Chronic Plaque Psoriasis (NCT01948271) | Tufts Medical Center | 2013-07-01 |
| Stem Cell Fistula Plug in Perianal Crohn's Disease (NCT01915927) | William A. Faubion, M.D. | 2013-07-01 |
| A Study to Evaluate Effect of Itraconazole on the Pharmacokinetics of Cobimetinib in Healthy Participants (NCT01929876) | Genentech, Inc. | 2013-07-01 |
| Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's Disease (NCT01864655) | Stephen M. Strittmatter | 2013-07-01 |
| Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults (NCT01879163) | University of Oxford | 2013-07-01 |
| Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD (NCT01911039) | Laura Johnston | 2013-07-01 |
| Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer (NCT01901653) | Stemcentrx | 2013-07-01 |
| CC-223 and Ketoconazole Drug-Drug Interaction Study (NCT01896323) | Celgene | 2013-07-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects (NCT01897779) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-07-01 |
| Evaluate the Safety and Feasibility of Injecting PMD-MSC Into the Penis to Treat the Symptoms of Mild to Moderate ED (NCT02398370) | Melissa Marchand | 2013-07-01 |
| Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer (NCT01898156) | Kyowa Kirin Korea Co., Ltd. | 2013-07-01 |
| A Study to Characterize the Abuse Liability of Intravenous Oxycodone Alone or in Combination With Intravenous Naltrexone in Healthy, Non-Dependent, Recreational Opioid Users (NCT01825447) | Pfizer | 2013-07-01 |
| A Phase I Study of IDP-73152 Mesylate in Health Male Volunteer (NCT01904318) | IlDong Pharmaceutical Co Ltd | 2013-07-01 |
| Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mg (NCT01926652) | Shin Poong Pharmaceutical Co. Ltd. | 2013-07-01 |
| Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy (NCT01889277) | Tanabe Pharma Corporation | 2013-07-01 |
| Pharmacokinetic, Safety, Tolerability and Immunogenicity Study of SB2 in Healthy Subjects (NCT01922336) | Samsung Bioepis Co., Ltd. | 2013-07-01 |
| Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms (NCT01908387) | Celgene Corporation | 2013-07-01 |
| Study to Define the Electrocardiogram Effects of a Single Dose of LX4211 in Healthy Subjects (NCT01913002) | Lexicon Pharmaceuticals | 2013-07-01 |
| A Phase I Study of High-dose L-methylfolate in Combination With Temozolomide and Bevacizumab in Recurrent High Grade Glioma (NCT01891747) | Vanderbilt-Ingram Cancer Center | 2013-07-01 |